X 
Xinjiang Tianshan Animal Husbandry Bio-Engineering Co 300313.SZ · CNY
Health Care · Shenzhen · 🇨🇳 China
11.51
+0.79%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥200.3m
FY2016FY2025
Net income
−CN¥27.2m
FY2016FY2025
Free cash flow
−CN¥4.2m
FY2016FY2025
Shareholders' equity
CN¥31.6m
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥200.3m | CN¥137.6m | CN¥137.5m | CN¥76.4m | CN¥108.0m | CN¥163.3m | CN¥229.0m | CN¥105.2m | CN¥195.3m | CN¥375.2m |
| Research and development | CN¥1.0m | CN¥1.2m | CN¥1.6m | CN¥565,274 | CN¥1.5m | CN¥763,945 | CN¥2.1m | CN¥1.3m | CN¥1.7m | CN¥4.9m |
| Operating income | −CN¥5.2m | −CN¥52.7m | −CN¥8.6m | −CN¥16.6m | −CN¥14.5m | CN¥15.9m | −CN¥92.3m | −CN¥1.93bn | CN¥11.2m | −CN¥191.8m |
| Net income | −CN¥27.2m | −CN¥65.9m | −CN¥22.0m | −CN¥31.8m | −CN¥27.3m | CN¥4.2m | −CN¥60.8m | −CN¥1.95bn | CN¥7.4m | −CN¥139.6m |
| Diluted earnings per share | -0.09 | -0.21 | -0.07 | -0.10 | -0.10 | 0.01 | -0.18 | -6.22 | 0.05 | -0.76 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥279.6m | CN¥248.2m | CN¥315.2m | CN¥332.1m | CN¥842.8m | CN¥907.0m | CN¥1.14bn | CN¥1.40bn | CN¥690.9m | CN¥855.4m |
| Cash and short-term investments | — | CN¥24.5m | CN¥16.7m | CN¥47.3m | CN¥108.9m | CN¥16.3m | CN¥22.1m | CN¥241.9m | CN¥28.5m | CN¥162.2m |
| Total liabilities | CN¥235.1m | CN¥242.5m | CN¥243.2m | CN¥238.0m | CN¥728.4m | CN¥758.0m | CN¥996.7m | CN¥1.20bn | CN¥328.4m | CN¥454.3m |
| Debt | CN¥30.6m | CN¥83.1m | CN¥176.8m | CN¥181.5m | CN¥220.6m | CN¥222.2m | CN¥204.1m | CN¥361.9m | CN¥213.7m | CN¥313.9m |
| Shareholders' equity | CN¥31.6m | −CN¥3.8m | CN¥62.2m | CN¥84.3m | CN¥104.1m | CN¥155.0m | CN¥149.2m | CN¥209.0m | CN¥363.6m | CN¥367.7m |
| Shares outstanding | 312m | 313m | 319m | 335m | 275m | 313m | 341m | 313m | 152m | 184m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥1.9m | CN¥14.4m | −CN¥13.7m | −CN¥7.6m | −CN¥35.1m | CN¥13.7m | −CN¥34.9m | −CN¥12.1m | CN¥78.7m | CN¥121.7m |
| Capital spending | −CN¥6.2m | −CN¥2.7m | −CN¥1.6m | −CN¥1.7m | −CN¥2.1m | −CN¥13.6m | −CN¥13.4m | −CN¥13.9m | −CN¥18.4m | −CN¥76.5m |
| Free cash flow | −CN¥4.2m | CN¥11.7m | −CN¥15.4m | −CN¥9.2m | −CN¥37.1m | CN¥122,888 | −CN¥48.3m | −CN¥26.0m | CN¥60.3m | CN¥45.2m |
| Dividends paid | −CN¥4.5m | −CN¥5.2m | −CN¥5.5m | −CN¥8.8m | −CN¥10.6m | −CN¥10.5m | −CN¥14.0m | −CN¥21.4m | −CN¥20.7m | −CN¥20.9m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥101.0m | CN¥118.6m | CN¥141.8m | CN¥16.9m | CN¥17.0m | CN¥24.6m | CN¥31.3m | CN¥59.0m |
| Operating income | CN¥848,564 | CN¥6.8m | −CN¥3.3m | −CN¥2.5m | CN¥1.1m | −CN¥1.3m | −CN¥25.7m | −CN¥9.7m |
| Net income | CN¥66,127 | CN¥4.2m | −CN¥15.5m | −CN¥3.9m | −CN¥2.8m | −CN¥5.0m | −CN¥24.3m | −CN¥13.8m |
| Diluted earnings per share | 0.00 | 0.01 | -0.05 | -0.01 | -0.01 | -0.02 | -0.08 | -0.04 |
| Cash from operations | — | — | — | −CN¥47.0m | CN¥3.0m | −CN¥5.0m | CN¥10.0m | CN¥1.0m |
| Capital spending | −CN¥2.0m | −CN¥1.0m | −CN¥3.0m | −CN¥1.0m | −CN¥1.0m | — | −CN¥1.0m | — |
| Free cash flow | — | — | — | −CN¥48.0m | CN¥2.0m | — | CN¥9.0m | — |
| Total assets | CN¥293.7m | CN¥295.1m | CN¥279.6m | CN¥277.5m | CN¥240.8m | CN¥239.7m | CN¥248.2m | CN¥274.5m |
| Cash and short-term investments | — | — | — | CN¥8.7m | CN¥19.0m | CN¥17.6m | CN¥24.5m | CN¥14.0m |
| Debt | CN¥30.5m | CN¥30.6m | CN¥30.6m | CN¥51.0m | CN¥80.2m | CN¥80.4m | CN¥80.4m | CN¥79.6m |
| Shareholders' equity | CN¥38.3m | CN¥36.7m | CN¥31.6m | CN¥34.4m | −CN¥11.6m | −CN¥8.7m | −CN¥3.8m | CN¥20.5m |
Financial ratios
Data as of 31 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | -6.3% | -38.2% | -6.0% | -21.4% | -13.0% | 9.7% |
| Net margin | -13.6% | -47.9% | -16.0% | -41.7% | -25.3% | 2.6% |
| Return on equity | -85.9% | 1745.0% | -35.4% | -37.8% | -26.2% | 2.7% |
| Return on assets | -9.7% | -26.6% | -7.0% | -9.6% | -3.2% | 0.5% |
| Free cash flow yield | 0.3% | 0.6% | -0.4% | -0.2% | -1.3% | 0.9% |
| Revenue growth | 45.6% | 0.1% | 80.1% | -29.3% | -33.9% | -28.7% |
| Earnings growth | -58.8% | 199.7% | -30.9% | 16.6% | -748.2% | -106.9% |
| Current ratio | 1.81x | 0.32x | 0.48x | 0.52x | 0.63x | 0.10x |
| Debt to equity | 0.97x | -21.27x | 2.81x | 2.14x | 2.10x | 1.43x |
| Equity ratio | 11.3% | -1.5% | 19.7% | 25.4% | 12.4% | 17.1% |
| Interest coverage | -1.37x | -4.87x | -0.75x | -1.16x | -0.96x | 1.26x |
| R&D as a share of sales | 0.5% | 0.9% | 1.2% | 0.7% | 1.4% | 0.5% |
| Buybacks as a share of market value | 0.2% | 2.0% | 4.6% | -21.9% | 12.3% | 8.1% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 37.9% | 4.2% | -2.1% |
| Operating income | -32.1% | — | -20.1% |
| Net income | -5.1% | — | -2.7% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -17.1% | -15.1% | -9.9% | -117.9% |
| Net margin | -27.6% | -26.6% | -20.7% | -118.7% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -92.2 | -27.5 | -142.8 | -64.8 | -77.3 | — | -30.5 | -1.0 | 246.8 | -25.0 |
| Price to sales | 12.5 | 13.2 | 22.9 | 27.0 | 19.6 | 41.7 | 8.1 | 18.8 | 9.4 | 9.3 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 8 May 2015.
| FY2015 | FY2014 | FY2012 | |
|---|---|---|---|
| Paid in the year | 0.025 | 0.025 | 0.05 |
- 2-for-1 split · 8 May 2015
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.